Background: Many strains of community-acquired methicillin-resistant Staphylococcus
Introduction
Community-acquired MRSA infection has been increasing worldwide 1 . The many strains of community-acquired MRSA have a phage harboring the Panton-Valentine leukocidin (PVL) genes. [2] [3] [4] PVL is a pore-forming leukotoxin, 5, 6 and PVL-positive S. aureus can cause primary skin and soft-tissue infections, 7 as well as severe necrotizing pneumonia in young immunocompetent patients. 6, 7 The mortality rate is 75%, 4 and autopsy reveals extensive necrotic and hemorrhagic lesions of the trachea, bronchi, alveolar septa, and parenchyma. Thus, new treatment strategies are needed for PVL-positive S. aureus.
Linezolid (LZD) has potent antibacterial activity against Gram-positive cocci, vancomycin-resistant enterococci, and MRSA. LZD was reported to be more effective than VCM in achieving microbiological eradication for the treatment of MRSA infections. 9 We established a mouse model of pulmonary infection with S. aureus by intravenous injection of bacteria enmeshed in agar beads. [10] [11] [12] The aim of the present study was to compare the activity and efficacy of LZD and VCM against PVL-positive S. aureus hematogenous pulmonary infection in a model mouse. Antibiotics LZD (Pfizer Japan Inc., Tokyo, Japan) and VCM (Shionogi Pharmaceutical Co., Osaka, Japan) were dissolved in sterile water immediately before use.
Materials and Methods

Determination of minimum inhibitory concentrations
The minimum inhibitory concentration (MIC) of each agent was determined by the microplate dilution technique. Mueller-Hinton II medium (Becton Dickinson and Company) and an inoculum size of 5 ×10
5 cfu/ml was used. MIC was defined as the lowest concentration of the test agent that inhibited visible growth of bacteria after 18
hours of incubation at 37°C.
Laboratory animals
Six-week-old, male, ddY, specific pathogen-free mice were purchased from Shizuoka Agricultural Cooperative Association Laboratory Animals (Shizuoka, Japan). All animals were housed in a pathogen-free environment and received sterile food and water in the Laboratory Animal Center for Nagasaki University Graduate School of Biomedical Sciences. The experimental protocol was approved by the Ethics Review
Committee for Animal Experimentation at Nagasaki University.
Inoculum
Inoculation was performed as previously described. 
Animal model of hematogenous pneumonia
A total of 0.25 ml of the suspension containing agar beads with bacteria was injected into the tail vein of each mouse (10 ml/kg of body weight). The method used for inducing infection has been described in detail elsewhere. [10] [11] [12] Treatment commenced a day after inoculation by intraperitoneal administration. Animals were allocated into 3 groups: LZD (100 mg/kg/dose), VCM (100 mg/kg/dose) or control. Each drug was administered twice daily for 1 day or 3 days for bacteriological study (n = 10 in each group), 3 days for histopathological and cytokine studies (n = 10 in each group), or 7 days for survival studies (n = 6 in each group).
Bacteriological, histopathological and survival examinations
Mice were sacrificed by cervical dislocation 12h after administration of antibiotics.
After exsanguinations, the lungs were dissected and removed under aseptic conditions.
Organs used for bacteriological analysis were homogenized and cultured quantitatively 7 by serial dilutions on Mueller Hinton II agar plates. Lung tissue for histological examination was fixed in 10% buffered formalin and stained with hematoxylin-eosin.
Specimens were examined under a microscope, and total abscesses were counted. The lung area was calculated by using cross-section paper.
Enzyme-linked immunosorbent assays (ELISA)
Concentrations of TNF-, MIP-2, and IL-1 in the lung homogenates were assayed by using mouse cytokine ELISA kits (R & D Systems, Minneapolis, MN, USA).
Statistical analysis
Bacteriological and cytokine data were expressed as means±SEM, and survival data were expressed by Kaplan-Meyer curves. Differences between groups were examined with the unpaired t-test. P values less than 0.05 were considered statistically significant.
Results
MIC of each antibiotic for PVL-positive S. aureus
The MIC of LZD and VCM for PVL-positive S. aureus was 2 g/ml and 1 g/ml, respectively.
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Bacteriological effects of antibacterial agents
When antibiotics were administrated for 1 day, the number of bacteria in the lungs in the control group, VCM group, and LZD group were 6.69±0.16, 6.52±0.21, and 6.30± 0.22 log cfu/ml, respectively (No statistically significant differences) (Fig. 1, panel a) .
When antibiotics were administrated for 3 days, the number of bacteria in the lungs in the control group was 6.77±0.14 (log cfu/ml). In contrast, the numbers in the VCM and LZD groups were 5.29±0.27 and 4.25±0.33 (log cfu/ml), respectively. The treatment with VCM significantly decreased the number of viable bacteria as compared with the control group (p = 0.0004). Furthermore, LZD administration resulted in a significant decrease in the number of viable bacteria when compared with that in the control group (p < 0.0001) or VCM group (p = 0.0088) (Fig. 1, panel b) .
Histopathological examination
Lung specimens from mice infected with PVL-positive S. aureus were microscopically examined 3 days after treatment, and lung abscesses consisting of bacterial colony with infiltrating acute inflammatory cells were found (Fig. 2) . The control (panel a) and VCM (panel b) groups exhibited numerous abscesses and inflammation. In contrast, the LZD group (panel c) exhibited fewer abscesses and less inflammation than the control and VCM groups.
In whole lung specimens, the number of abscesses in control, VCM, and LZD groups were 15.6±4.25, 10.2±3.31, and 2.6±0.93, respectively (Fig. 3, panel a) . The number of abscesses per cm 2 also showed similar consequents (control, VCM, and LZD groups were 10.6±3.08, 5.89±1.91, and 1.58±0.53 count per cm 2 , respectively) ( Fig.   3, panel b) . The numbers of abscesses in whole lungs and per lung area were significantly decreased in the LZD group, as compared with those in the control group (p = 0.013 and 0.011, respectively). There were no significant differences in the number of abscesses in whole lungs and per lung area between the control and VCM groups and between the VCM and LZD groups.
Cytokine concentrations in lung extracts
When antibiotics were administrated for 3 days, the concentrations of proinflammatory cytokines, TNF-, MIP-2, and IL-1, were significantly lower in the VCM and LZD groups as compared with the concentrations in the control group. In addition, all of these cytokine concentrations were lower in the LZD group than in the VCM group; however, the difference was not statistically significant (Fig. 4) .
Survival study
The survival rate at day 7 post-inoculation was higher in the LZD group (100% survival) when compared with the VCM group (50%) and the control group (all dead within 6 days) (Fig. 5) .
Discussion
The present study is the first report to demonstrate the establishment of the mouse model of PVL-positive S. aureus hematogenous pulmonary infection. Moreover, this model was used to compare the efficacy of LZD and VCM. LZD showed beneficial efficacy on bacteriological and histopathological examinations, cytokine levels, and survival rates.
We previously reported the effect of LZD against a mouse model of hematogenous pulmonary infection with MRSA NUMR101, which was isolated from clinical samples at Nagasaki University Hospital. 10 The results of that study are identical to those in the present study, with the exception of the cytokine analysis. The present cytokine analysis showed that proinflammatory cytokines, TNF-, MIP-2, and IL-1, were obviously decreased in the LZD group. This finding supports that LZD significantly reduces the number of bacteria and level of inflammation in the lungs.
In the present study, although the MIC of LZD for PVL-positive S. aureus was higher than that of VCM, LZD was more effective than VCM against PVL-positive S. aureus infection model. Specimens were examined under a microscope, and lung area was determined by using cross-section paper.
